IND: Call Us +91 983 481 6757 | CANADA: Call Us +1 215 297 4078
  • Email [email protected]

Contrive Datum Insights

  • Home
  • Services
  • CATEGORIES
  • PRESS RELEASE
  • LATEST REPORTS
  • ABOUT US
  • CONTACT US
  1. Home
  2. Medical Devices
  3. Monogenetic Disorders Testing Market
Monogenetic Disorders Testing Market - Global Industry Analysis, Size, Share, Growth Opportunities, Future Trends, Covid-19 Impact, SWOT Analysis, Competition, and Forecasts 2022 to 2030

Monogenetic Disorders Testing Market - Global Industry Analysis, Size, Share, Growth Opportunities, Future Trends, Covid-19 Impact, SWOT Analysis, Competition, and Forecasts 2022 to 2030

Region : Global | Format : report format | Report ID : 10603 | No. of Pages : 250

  • DESCRIPTION
  • TABLE OF CONTENT
  • METHODOLOGY
  • REPORT SCOPE

The Monogenetic Disorders Testing market is expected to grow at a CAGR of 11% during the forecast period 2022-2030.

Monogenetic Disorders Testing Market Overview

According to Mendel's laws, monogenic disorders are inherited due to a single defective gene on an autosome. Monogenic disorders are caused by a single mutated gene that can be found on one or both chromosomes. Due to an autosomal disorder, the disorder affects males and females equally. Cystic fibrosis, sickle cell anemia, SCID, Tay-Sachs disease, polycystic kidney disease, Gaucher disease, Huntington's disease, neurofibromatosis, thalassemia, and familial hypercholesterolemia are common monogenic disorders, Can be tested.

Contrive Datum Insights have recently published the Monogenetic Disorders Testing Market to its huge database which helps to shape the future of businesses by making well-informed business decisions. It offers a comprehensive analysis of various business aspects such as global market trends, recent technological advancements, market size, shares, and new innovations. Furthermore, this analytical data has been compiled through data exploratory techniques such as primary and secondary research. Moreover, an expert team of researchers throws light on various static as well as dynamic aspects of the global Monogenetic Disorders Testing market.

Some of the key players profiled in the study are:

Different leading key players have been profiled to get better insights into the businesses. It offers detailed elaboration on different top-level industries which are functioning in global regions. It includes informative data such as company overview, contact information, and some significant strategies followed by key players: Celera Group, Abbott, Thermo Fisher Scientific, ELITech Group, Quest, AutoGenomics, and others.

What are the major Applications, Types, and Regions for the Monogenetic Disorders Testing Market?

Test Type

  • Carrier Testing
  • Diagnostic Testing
  • New-Born Screening
  • Predictive and Pre-Symptomatic Testing
  • Prenatal Testing

 Disease Type

  • Cystic fibrosis
  • Sickle Cell Anemia
  • Severe Combined Immunodeficiency (SCID)
  • Tay-Sachs Disorder
  • Polycystic Kidney Disorder
  • Gaucher's Disease
  • Huntington's Disease
  • Neurofibromatosis
  • Thalassaemia
  • Familial Hypercholesterolemia

 End Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics

Monogenetic Disorders Testing Market Regional Insights:

The Monogenetic Disorders Testing market is analyzed and market size insights and trends are provided by country, test type, disease type, and end use as mentioned above. North America dominates the Monogenetic Disorders Testing market owing to its high level of intelligence and growing awareness about Monogenetic Disorders Testing procedures. Asia Pacific is expected to grow at the highest growth rate over the forecast period 2022 to 2029 owing to the presence of a large number of organizations focused on Disorders management.

Geographically, the global Monogenetic Disorders Testing market has been analyzed in various regions such as North America, Europe, Asia-Pacific, Latin America, the Middle East, and India. The global region is dominating this market in the upcoming future.

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Nordic Countries
      • Denmark
      • Finland
      • Iceland
      • Sweden
      • Norway
    • Benelux Union
      • Belgium
      • The Netherlands
      • Luxembourg
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Southeast Asia
      • Indonesia
      • Thailand
      • Malaysia
      • Singapore
      • Rest of Southeast Asia
    • Rest of Asia-Pacific
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Monogenetic Disorders Testing Market Report Scope:

Report Attributes

Details

Growth Rate

CAGR of 11% from 2022 to 2030.

Test Type

  • Carrier Testing
  • Diagnostic Testing
  • New-Born Screening
  • Predictive and Pre-Symptomatic Testing
  • Prenatal Testing

Disease Type

  • Cystic fibrosis
  • Sickle Cell Anemia
  • Severe Combined Immunodeficiency (SCID)
  • Tay-Sachs Disorder
  • Polycystic Kidney Disorder
  • Gaucher's Disease
  • Huntington's Disease
  • Neurofibromatosis
  • Thalassaemia
  • Familial Hypercholesterolemia

End Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics

By Companies 

Celera Support Services (U.S.), Abbott (U.S.), ELITech Group (U.S.), Quest Diagnostics Incorporated (U.S.), Auto Genomics (U.S.), PerkinElmer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.)

Regions and Countries Covered

  • North America: (US, Canada, Mexico, Rest of North America)
  • Europe(Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific)
  • The Middle East & Africa(Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa)
  • Latin America(Brazil, Argentina, Rest of Latin America)
  • Rest Of the World

Base Year

 2022

Historical Year

 2017 to 2022

Forecast Year

 2023 to 2030

Frequently Asked Questions (FAQ) about the Monogenetic Disorders Testing market:

What is the CAGR of the global Monogenetic Disorders Testing market?

The Monogenetic Disorders Testing Market is growing at a CAGR of 11% during the forecast period.

Which region would offer high growth for vendors in the Monogenetic Disorders Testing market?

North America dominates the Monogenetic Disorders Testing market

Which Is the Most potential market segment?

Test Type

  • Carrier Testing
  • Diagnostic Testing
  • New-Born Screening
  • Predictive and Pre-Symptomatic Testing
  • Prenatal Testing

Which are the top industry players in the Monogenetic Disorders Testing market?

Celera Group, Abbott, Thermo Fisher Scientific, ELITech Group, Quest, AutoGenomics

All of our reports are custom to your company's needs to some extent and we offer 5 hours of free consultation time with each report purchase, which will allow you to request any additional data to custom the report to your needs.
Choose License Type

Flat 20% Discount

  • Single User   USD 4500   5625
  • Multi User   USD 5800   7250
  • Enterprise User   USD 7000   8750
Request Sample
Inquire Before Buying
Get Special Pricing

Speak to the Analyst

Email Us

Contact Us

Related Reports

Report name Published Month
Gastrointestinal Endoscopy Device Market Size, Share & Trends Estimation Report By Type Outlook (Audio And Video Equipment, Semiconductor And Other Electronic Components) By Sales Outlook (OEM And Aftermarket Semiconductor & Other Electronic Components) By End Use Outlook (Business To Business (B2B) & Business To Customer (B2C)) By Region, And Segment Forecasts, 2022 - 2030 March 2023 Get sample pdf
Cancer Immunotherapy Market Size, Share & Trends Estimation Report By Product Type Outlook (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies and Cancer Vaccines) By Application Outlook (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Ovarian Cancer, Pancreatic Cancer & Others) By Distribution Outlook (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) By Region, And Segment Forecasts, 2022 - 2030 March 2023 Get sample pdf
Acne Market Size, Share & Trends Estimation Report By Product Outlook (Mask, Creams & Lotions, Cleansers & Toners & Others) By Gender Outlook (Women & Men) By End Use Outlook (Dermatology Clinics & MedSpa) By Region, And Segment Forecasts, 2022 - 2030 March 2023 Get sample pdf
Contrive Datum Insights
  • FAQ’s
  • Payment Procedures
  • Sitemap
  • About us
  • Our Services
  • Contact Us
  • Become a Publisher
  • Terms and Conditions
  • Refund or Cancellation policy
  • Privacy policy
  • Disclaimer
  • ccavenue
  • visa
  • mastercard
Copyright© All Rights Reserved by Contrive Datum Insights Pvt. Ltd. All Rights Reserved.